Search - tctmd.com

Displaying 241 - 260 of 485

Sort: Relevancy | Date

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

Presentation PCR London Valves 2017

Aortic Stenosis: Anatomy, Physiology and Pathology

Presenter: Marjo de Ronde-Tillmans

September 25, 2017

News Conference News PCR London Valves 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

News Daily News

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Caitlin E. Cox

September 06, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 2

Presenter: Mauricio G. Cohen

August 30, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

Podcast TCTMD Talking Points

Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis

August 02, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Conference News SCCT 2017

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Yael L. Maxwell

July 08, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

Presenter: Martin B. Leon, Hendrik Treede, Philippe Pibarot

June 16, 2017

Presentation TVT 2017

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Presenter: David J. Cohen, Mark J. Russo, Adam Castano

June 16, 2017

Advertisement

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

Aortic Stenosis: Anatomy, Physiology and Pathology

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Complications of Structural Heart Disease Intervention - Part 2

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content